The National Medical Products Administration (NMPA) is a regulatory authority in China responsible for overseeing the safety and effectiveness of medical products. This includes pharmaceuticals, medical devices, and cosmetics. The NMPA ensures that these products meet strict quality standards before they can be marketed and used by the public. Established in 2018, the NMPA operates under the State Administration for Market Regulation. Its main functions include reviewing product applications, conducting inspections, and monitoring post-market safety. By regulating medical products, the NMPA aims to protect public health and promote the development of the medical industry in China.